Navigation Links
Mylan Completes Acquisition of Bioniche Pharma Sooner Than Expected
Date:9/7/2010

e to unlock additional efficiencies in their operations, help lower costs and improve patient care."

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit www.mylan.com.

This press release includes statements that constitute "forward-looking statements," including with regard to the expected future business and financial performance of Mylan resulting from and following such transaction. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: challenges and costs relating to integration of the business into the company; the effect of any changes in customer and supplier relationships and customer purchasing patterns; the impact and effects of legal or regulatory proceedings, actions or changes; general market perception of the transaction; exposure to lawsuits and contingencies associated with both companies' businesses; the ability to attract and retain key personnel; prevailing market conditions; changes in economic and financial conditions of the company's business; uncertainties and matters beyond the control of management; and the other risks detailed in the company's filings with the Securities and Exchange Commission. The compa
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014   GS1 US ... implement GS1 Standards to support the 2013 Drug ... safety and security in the pharmaceutical supply chain. ... to U.S. Pharmaceutical Supply Chain Business Processes to ... was developed in collaboration with GS1 Healthcare ...
(Date:9/17/2014)... -- Sutro Biopharma, a biopharmaceutical company developing antibody drug ... Merck KGaA, Darmstadt, Germany , which ... States and Canada , ... antibody drug conjugates (ADCs). ADCs are composed of an ... thought to specifically target and deliver the cytotoxic drug ...
(Date:9/17/2014)... ARMONK, N.Y. , Sept. 17 2014 ... Caris Life Sciences is using IBM technical computing ... profiling services for cancer patients. These services deliver ... therapeutic plans for each patient,s unique cancer, which ... costs to the healthcare system in general. ...
Breaking Medicine Technology:New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 3New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 4Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 2Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 4Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 2Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 3Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 4
... MALVERN, Pa., May 17, 2012  Egalet Ltd., a privately ... and abuse-deterrent medications, announced today Bob Radie, president and ... Life Sciences Europe conference on May 23 organized ... the company,s patented technology and pipeline of abuse-deterrent opioids ...
... LOUIS, May 17, 2012 , "9 Trends" ... , Helping Members Make Healthier Decisions , ... , Developing New Ways to Comprehensively Manage Specialty Care ... Poor health choices add billions in cost to ...
Cached Medicine Technology:Egalet to Present at Life Sciences Europe Conference 2Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 2Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 3Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 4Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 5
(Date:9/17/2014)... Dennis Thompson HealthDay ... -- Diabetics and dieters who turn to artificial sweeteners ... themselves any favors, a new Israeli study suggests. ... despite containing no calories, researchers found in human and ... appear to alter the bacteria residing in the intestines ...
(Date:9/17/2014)... more than 87,000 men, a global team of scientists ... common differences in the genetic code -- that increase ... believed to be the largest of its kind, has ... array of ethnic groups comprising men of European, African, ... from smaller studies, according to William B. Isaacs, Ph.D., ...
(Date:9/17/2014)... Mercy “topped out” the world’s first ... beam into place. Sister of Mercy Claudia Ward also ... and video of the event, including footage from an ... http://bit.ly/MercyVirtual .) , “The topping out means we are ... thousands of patients regardless of the hour or location,” ...
(Date:9/17/2014)... Fremont, California (PRWEB) September 17, 2014 ... remote access connectivity solutions, today announced that it ... Appliance in October 2014. This new offering will ... 365 and other Software-as-a-Service applications to enable secure ... With the rise of cloud computing, there has ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. ... companies have made good on their pledge to cut calories ... companies, acting together through the Healthy Weight Commitment Foundation, pledged ... and 2012 and 1.5 trillion by 2015. They,ve actually reduced ... met their pledge and exceeded their pledge," said lead researcher ...
Breaking Medicine News(10 mins):Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 2Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 3Health News:Large study reveals new genetic variants that raise risk for prostate cancer 2Health News:Mercy Tops Out World's First Virtual Care Center 2Health News:Celestix Announces Availability of ADFS Bridge Appliance in October 2014 to Simplify the Configuration of Office 365 with Active Directory 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 3
... Kiley Carlson of Sioux City, IA will travel ... 31, 2009 to meet with congressional leaders and gain ... research toward a cure for epilepsy.Carlson, 16, is one ... in Kids Speak Up! , a national program ...
... Findings of Pilot Study at East African Health Conference ... Danya International, Inc. (Danya), a communications, research, ... pilot study on the effectiveness of mobile video-enabled phones ... tuberculosis (TB) patients during the 3rd East African Health ...
... Milwaukee MD Saves Patients Money and Improves Health ... To save you money and save your ... may need to be part medical detective as ... http://www.newscom.com/cgi-bin/prnh/20090323/NY86411-a ) , (Photo: http://www.newscom.com/cgi-bin/prnh/20090323/NY86411-b ...
... HOUSTON - Just more than one year after it was ... of Texas M. D. Anderson Cancer Center has introduced a ... generations of women scientists to come. , Legends and ... D. Anderson Cancer Center presents the reflections of 26 current ...
... statutory health insurances in Germany have offered an endoscopic ... all insured persons from the age of 55. Germany ... for bowel cancer a part of its statutory early ... Professor Hermann Brenner at DKFZ have now published a ...
... Scientists at the University of Liverpool have demonstrated how ... be a source of Salmonella transmission to ... living creatures that can contaminate almost any food type, ... that Salmonella which can also cause ...
Cached Medicine News:Health News:Iowa Youth Shares Epilepsy Message on Capitol Hill 2Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 2Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 3Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 4Health News:Saving Money While Protecting Your Health in Tough Economic Times 2Health News:Saving Money While Protecting Your Health in Tough Economic Times 3Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 2Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 3Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 4Health News:Germany: Colonoscopy prevents 15,000 cancer cases 2Health News:Study shows how Salmonella survives in environment 2
Two-channel, Berman design. Semirigid, nontoxic polyethylene. Individually packaged, 48 per case. Latex Free....
Black elastomer. Smooth finish. Non-Sterile....
Guedel-style enclosed center channel. Semirigid, nontoxic polyethylene with color-coded bite block. Individually packaged, 48 per case. Latex Free....
Includes one of each size airway. Plastic. Color coded for size. Single use. Non-Sterile....
Medicine Products: